Meningitis Outbreak Traced To Framingham Pharmacy
The New England Compounding Center is shown here on October 5, 2012 in Framingham, Massachusetts.  Jared Wickerham—Getty Images

Pharma Company Behind Meningitis Outbreak to Shell Out $100 Million

May 07, 2014

Attorneys in New England reached a proposed $100 million settlement on Tuesday with the owners of the pharmaceutical operation that produced tainted drugs responsible for the 2012 nationwide meningitis outbreak that killed 64 people.

The $100 million deal will provide compensation to insurers and victims of the outbreak in accordance with a Chapter 11 plan filed by the owners of New England Compounding Pharmacy Inc., according to Bloomberg.

The outbreak, which infected more than 700 people, was largely blamed on a steroid administered by spinal injection that was produced by the company.

A judge must still approve the settlement along with a system that will distribute the funds to victims awaiting compensation.

TIME may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.